AA
FOLD

Ancora Advisors’s Amicus Therapeutics FOLD Stock Holding History

Ancora Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,694
Closed -$22K – 1997
2025
Q1 		$22K Hold
2,694
– – ﹤0.01% 1177
2024
Q4 		$25.4K Hold
2,694
– – ﹤0.01% 1161
2024
Q3 		$28.8K Hold
2,694
– – ﹤0.01% 1124
2024
Q2 		$26.7K Hold
2,694
– – ﹤0.01% 1104
2024
Q1 		$31.7K Hold
2,694
– – ﹤0.01% 1087
2023
Q4 		$38.2K Hold
2,694
– – ﹤0.01% 1009
2023
Q3 		$32.8K Hold
2,694
– – ﹤0.01% 1022
2023
Q2 		$33.8K Buy
+2,694
New +$32K ﹤0.01% 1006
2021
Q2 		– Sell
-135
Closed -$1K – 1955
2021
Q1 		$1K Hold
135
– – ﹤0.01% 1675
2020
Q4 		$3K Hold
135
– – ﹤0.01% 1338
2020
Q3 		$2K Hold
135
– – ﹤0.01% 1314
2020
Q2 		$2K Hold
135
– – ﹤0.01% 1273
2020
Q1 		$1K Hold
135
– – ﹤0.01% 1385
2019
Q4 		$1K Buy
+135
New +$1.24K ﹤0.01% 1333

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ancora Advisors's FOLD Position: Q2 2025 in Review

Ancora Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2025, closing a stake of 2,694 shares — an estimated $22K sold.

Ancora Advisors first reported a position in FOLD in Q4 2019 and held it in 14 quarters. The position peaked at $38.2K in Q4 2023. 272 funds tracked by Wall St. Rank hold FOLD as of Q2 2025.

  • Ancora Advisors reported no remaining Amicus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ancora Advisors sold 2,694 Amicus Therapeutics shares in Q2 2025, an estimated $22K.
  • Ancora Advisors first reported a position in Amicus Therapeutics in Q4 2019 and held it in 14 quarters.
  • Ancora Advisors's Amicus Therapeutics position peaked at $38.2K in Q4 2023.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2025.

Based on Ancora Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.